Charles S Berkman Insider Trading $LGND LIGAND PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Charles S Berkman.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Charles S Berkman. Charles S Berkman is Asso. Gen. Counsel, Secretary in LIGAND PHARMACEUTICALS INC ($LGND) and SVP, Gen. Counsel & Secretary in LIGAND PHARMACEUTICALS INC ($LGND) and VP, Gen. Counsel & Secretary in LIGAND PHARMACEUTICALS INC ($LGND).

Charles S Berkman in LIGAND PHARMACEUTICALS INC

Trading Symbol: LGND
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles S Berkman: SVP, Gen. Counsel & Secretary, VP, Gen. Counsel & Secretary, Asso. Gen. Counsel, Secretary
Holdings: 47,003 shares
Current Value: $5,068,804
Latest Transaction: Feb 05 2021
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Charles S Berkman in LIGAND PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 05 2021LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseA177.506,9551,234,5136,955
Feb 05 2021LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...SellS178.5018,0973,230,37628,90647 K to 28.9 K (-38.50 %)
Feb 05 2021LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.003,491047,00343.5 K to 47 K (+8.02 %)
Jan 27 2021LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF156.01830129,48843,51244.3 K to 43.5 K (-1.87 %)
Jan 27 2021LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.002,401044,34241.9 K to 44.3 K (+5.72 %)
Jan 27 2021LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF156.1050979,45541,94142.5 K to 41.9 K (-1.20 %)
Jan 27 2021LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.001,335042,45041.1 K to 42.5 K (+3.25 %)
Jul 01 2020LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyJ89.0323821,18941,11540.9 K to 41.1 K (+0.58 %)
Jun 05 2020LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...SellS118.5911,1461,321,77540,87752 K to 40.9 K (-21.43 %)
Feb 18 2020LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseA95.6817,2201,647,61017,220
Feb 18 2020LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF97.2336735,68352,02352.4 K to 52 K (-0.70 %)
Feb 18 2020LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF97.2320720,12752,39052.6 K to 52.4 K (-0.39 %)
Feb 18 2020LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF97.2330729,85052,59752.9 K to 52.6 K (-0.58 %)
Feb 18 2020LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.003,835052,90449.1 K to 52.9 K (+7.82 %)
Dec 26 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF105.8754657,80549,06949.6 K to 49.1 K (-1.10 %)
Dec 26 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.001,335049,61548.3 K to 49.6 K (+2.77 %)
Dec 26 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF105.8758561,93448,28048.9 K to 48.3 K (-1.20 %)
Dec 26 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.001,693048,86547.2 K to 48.9 K (+3.59 %)
Aug 06 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM85.7942436,3754,153
Aug 06 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM56.2666937,6381,948
Aug 06 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM85.7942436,37547,17246.7 K to 47.2 K (+0.91 %)
Aug 06 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM56.2666937,63846,74846.1 K to 46.7 K (+1.45 %)
Jul 02 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyJ97.0318217,65946,07945.9 K to 46.1 K (+0.40 %)
Jan 25 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.001,412042,69541.3 K to 42.7 K (+3.42 %)
Jan 25 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.001,370041,28339.9 K to 41.3 K (+3.43 %)
Jan 14 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM74.421,931143,7050
Jan 14 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM56.2667537,9762,617
Jan 14 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM21.922445,3480
Jan 14 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM56.2667537,97639,91339.2 K to 39.9 K (+1.72 %)
Jan 14 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM74.421,931143,70539,23837.3 K to 39.2 K (+5.18 %)
Jan 14 2019LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM21.922445,34837,30737.1 K to 37.3 K (+0.66 %)
Dec 17 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM21.923,40074,528244
Dec 17 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM21.923,40074,528244
Dec 17 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM21.923,40074,52837,06333.7 K to 37.1 K (+10.10 %)
Dec 17 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM21.923,40074,52837,06333.7 K to 37.1 K (+10.10 %)
Oct 25 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM14.472,68838,8950
Oct 25 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM21.921,21226,5673,644
Oct 25 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM21.921,21226,56733,66332.5 K to 33.7 K (+3.73 %)
Oct 25 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM14.472,68838,89532,45129.8 K to 32.5 K (+9.03 %)
Oct 12 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM14.472,00028,9402,688
Oct 12 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM14.472,00028,94029,76327.8 K to 29.8 K (+7.20 %)
Sep 18 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM100.382,813282,3696,830
Sep 18 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...SellS250.692,813705,18127,76330.6 K to 27.8 K (-9.20 %)
Sep 18 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM100.382,813282,36930,57627.8 K to 30.6 K (+10.13 %)
Sep 05 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM21.9246910,2800
Sep 05 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM85.795,886504,9604,577
Sep 05 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM74.425,985445,4041,931
Sep 05 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseM56.267,077398,1523,292
Sep 05 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...SellS254.9919,4174,951,06527,76347.2 K to 27.8 K (-41.16 %)
Sep 05 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM85.795,886504,96047,18041.3 K to 47.2 K (+14.25 %)
Sep 05 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM56.267,077398,15241,29434.2 K to 41.3 K (+20.68 %)
Sep 05 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM74.425,985445,40434,21728.2 K to 34.2 K (+21.20 %)
Sep 05 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyM21.9246910,28028,23227.8 K to 28.2 K (+1.69 %)
Jul 03 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...BuyJ117.8418021,21027,76327.6 K to 27.8 K (+0.65 %)
Mar 06 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseA159.019,2921,477,5219,292
Mar 06 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF165.8739265,02127,58328 K to 27.6 K (-1.40 %)
Mar 06 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.001,136027,97526.8 K to 28 K (+4.23 %)
Mar 06 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.001,780026,83925.1 K to 26.8 K (+7.10 %)
Feb 16 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF157.1826040,86725,05925.3 K to 25.1 K (-1.03 %)
Feb 16 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF157.1825239,60925,31925.6 K to 25.3 K (-0.99 %)
Feb 16 2018LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Payment of ExerciseF157.1852482,36225,57126.1 K to 25.6 K (-2.01 %)
Dec 29 2017LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Payment of ExerciseF138.661,175162,92626,09527.3 K to 26.1 K (-4.31 %)
Dec 29 2017LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...GrantA0.002,847027,27024.4 K to 27.3 K (+11.66 %)
Aug 10 2017LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS126.9618,6252,364,67124,42343 K to 24.4 K (-43.27 %)
Jul 05 2017LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyJ87.1324321,17143,04842.8 K to 43 K (+0.57 %)
Feb 28 2017LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseA100.389,643967,9649,643
Feb 28 2017LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...GrantA0.002,259042,80540.5 K to 42.8 K (+5.57 %)
Feb 28 2017LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...GrantA0.002,619040,54637.9 K to 40.5 K (+6.91 %)
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM21.924,29594,146469
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM74.4212,084899,2917,916
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM56.265,688320,00710,369
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM42.904,947212,2260
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM40.863,333136,1860
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM40.863,333136,18637,92734.6 K to 37.9 K (+9.63 %)
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM42.904,947212,22634,59429.6 K to 34.6 K (+16.69 %)
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS123.1612,0841,488,26529,64741.7 K to 29.6 K (-28.96 %)
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM74.4212,084899,29141,73129.6 K to 41.7 K (+40.76 %)
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS123.165,688700,53429,64735.3 K to 29.6 K (-16.10 %)
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM56.265,688320,00735,33529.6 K to 35.3 K (+19.19 %)
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS123.164,295528,97229,64733.9 K to 29.6 K (-12.65 %)
Aug 09 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM21.924,29594,14633,94229.6 K to 33.9 K (+14.49 %)
Feb 16 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseA85.7910,463897,62110,463
Feb 16 2016LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...GrantA0.002,193029,64727.5 K to 29.6 K (+7.99 %)
Jul 14 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM14.478,442122,1564,688
Jul 14 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM53.101,00053,1000
Jul 14 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM10.055,62556,5310
Jul 14 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM53.101,00053,10027,45426.5 K to 27.5 K (+3.78 %)
Jul 14 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS99.862,825282,10526,45429.3 K to 26.5 K (-9.65 %)
Jul 14 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS99.188,838876,55329,27938.1 K to 29.3 K (-23.19 %)
Jul 14 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS98.152,404235,95338,11740.5 K to 38.1 K (-5.93 %)
Jul 14 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM14.478,442122,15640,52132.1 K to 40.5 K (+26.32 %)
Jul 14 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM10.055,62556,53132,07926.5 K to 32.1 K (+21.26 %)
Jul 01 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyJ45.6746521,23726,45426 K to 26.5 K (+1.79 %)
Mar 18 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM21.924,13090,5304,764
Mar 18 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM14.471,13416,4090
Mar 18 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS74.584,130308,01525,98930.1 K to 26 K (-13.71 %)
Mar 18 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM21.924,13090,53030,11926 K to 30.1 K (+15.89 %)
Mar 18 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS74.581,13484,57425,98927.1 K to 26 K (-4.18 %)
Mar 18 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM14.471,13416,40927,12326 K to 27.1 K (+4.36 %)
Mar 18 2015LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS74.516,000447,06025,98932 K to 26 K (-18.76 %)
Jan 28 2010LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseA2.696,00016,1406,000
Jan 05 2010LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyJ1.846,70712,37161,97055.3 K to 62 K (+12.14 %)
Feb 18 2009LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseA2.69100,000269,000100,000
Feb 18 2009LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...GrantA0.0018,000055,26337.3 K to 55.3 K (+48.31 %)
Feb 18 2009LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...GrantA0.007,000037,26330.3 K to 37.3 K (+23.13 %)
Jan 27 2009LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseA3.507,00024,5007,000
Feb 26 2008LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseA3.5080,000280,00080,000
Feb 26 2008LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...GrantA0.0018,000030,26312.3 K to 30.3 K (+146.78 %)
Jun 22 2007LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseA7.1532,000228,80032,000
Jun 22 2007LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...GrantA0.0011,000012,2631.3 K to 12.3 K (+870.94 %)
May 02 2007LGNDLIGAND PHARMACEUTI ...Berkman Charles SAsso. Gen. Counsel, ...Option ExerciseA6.8120,000136,20020,000

Page:   1

Contact us | Follow us on Twitter